BIOLOX
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

BIOLOX Trademark

Serial Number: 79278180 • Registration: 6297509

BIOLOX is a trademark filed by Cerasiv GmbH Innovatives Keramik-Engineering on September 24, 2019. The trademark is classified under Class 1 (Chemicals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Cerasiv GmbH Innovatives Keramik-Engineering

Fabrikstrasse 23

Entity Type: 27

Trademark Details

Filing Date

September 24, 2019

Registration Date

March 23, 2021

Published for Opposition

January 5, 2021

Goods & Services

Marketing; business administrative assistance in the field of marketing authorisation procedures; business administrative services relating to referrals of documents to public authorities or government agencies; business advice on product development strategies; organisation of trade fairs and presentations for others for advertising to customers and industry representatives; regulatory submission management, namely, assisting others in preparing applications for approval to market new drugs with governmental regulatory bodies, as required under pharmaceutical law; compilation of medical business reports

Health care for human beings; medical services; medical assessments being physical evaluations; medical information; medical consultancy services; medical testing for diagnostic or treatment purposes; performance of health consultancy services; consultancy and information services on medical diagnosis and treatment using medical products; consultancy services relating to medical treatments using orthopaedic, prosthetic, and dental implants

Publication of medical journals, books and manuals; medical training; providing further medical training, namely, continuing medical education courses

Scientific and technological services, namely, medical research; engineering services; development of pharmaceutical products and conducting clinical trials for others; research and development services for new products for third parties; quality testing of pharmaceutical products, conducting scientific research and research in the fields of medicine and pharmacy

Medical apparatus and instruments, namely, artificial orthopaedic and dental implants, and prosthetic hands, hips, knees, ligaments; Medical apparatus and instruments for surgically implanting orthopaedic, prosthetic, and dental implants; prostheses for hands, hips, knees, shoulders; artificial bone implants; surgical appliances, namely, orthopedic fixation device used in orthopedic transplant and/or implant surgery and surgical devices and instruments for surgery; medical equipment for use in surgery, namely, surgical instruments; implants for osteosynthesis, namely, metal screws, plates, pins, and pivots; artificial bone implants for osteosynthesis; endoprostheses in the nature of joint prostheses; anchorages being artificial medical implants for anchoring endoprostheses; artificial medical implants for spacing bones

Chemical substances, namely, ceramic, mixed oxide ceramic, zirconia toughened ceramic compounds for manufacturing artificial implants and prostheses; chemical preparations for manufacturing biomedical implants

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 23, 2026 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 14, 2021 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Jul 2, 2021 XXSS
GENERIC MADRID TRANSACTION CREATED
Jul 2, 2021 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 23, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 23, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Jan 10, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 5, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jan 5, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 23, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 23, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 16, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 2, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 25, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 25, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 25, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 25, 2020 CNEA
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 24, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 24, 2020 GNSL
SUSPENSION LETTER WRITTEN
Aug 24, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 29, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 28, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 28, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 13, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 13, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 13, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 13, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 13, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 13, 2020 COAR
REFUSAL PROCESSED BY IB
Mar 28, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 10, 2020 RFCS
REFUSAL PROCESSED BY MPU
Mar 10, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 19, 2020 RFCR
NON-FINAL ACTION WRITTEN
Feb 18, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 15, 2020 MAFR
ASSIGNED TO EXAMINER
Feb 11, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 6, 2020 REPR